PharmaCyte Biotech Inc (PMCB)

[TheBestInvest]

Ok but we all know the current PPS is absolutely irrelevant once this hits FDA approval. It will run on its own immediately after ,and, if a buyout is offered, it would be a set price based off what they believe the pancreatic cancer market is worth. We are talking about this being a gold standard treatment.

On top of that Ciab can be used for other cancers and diabetes- which alone produces an annual $250 BILLION.

I think you're missing part of the picture on how much potential is here.